Literature DB >> 14510816

Epilepsy and comorbidity: infections and antimicrobials usage in relation to epilepsy management.

J W Sander1, E Perucca.   

Abstract

Infections are probably the most common preventable cause of epilepsy worldwide. There are concerns that endemic infections and infestations, such as malaria and neurocysticercosis, could be responsible for the increased incidence of epilepsy in the developing world. Cases of epilepsy associated with neurocysticercosis are also being seen increasingly in developed countries due to migration from, and travel to, endemic areas. When prescribing antimicrobial agents in patients with epilepsy a number of issues need to be considered, such as potential adverse effects on seizure control and interactions with concomitant antiepileptic drugs (AEDs). Some antimicrobial agents, including penicillins, cephalosporins, carbapenems, quinolones and antimalarials, can have proconvulsant activity and may precipitate seizures, even in patients who do not have epilepsy. Moreover, many antimicrobials increase or decrease the plasma levels of AEDs, whereas some AEDs may adversely affect the efficacy of antimicrobials.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14510816     DOI: 10.1034/j.1600-0404.108.s180.3.x

Source DB:  PubMed          Journal:  Acta Neurol Scand Suppl        ISSN: 0065-1427


  9 in total

Review 1.  Infections, inflammation and epilepsy.

Authors:  Annamaria Vezzani; Robert S Fujinami; H Steve White; Pierre-Marie Preux; Ingmar Blümcke; Josemir W Sander; Wolfgang Löscher
Journal:  Acta Neuropathol       Date:  2015-09-30       Impact factor: 17.088

2.  Cefixime-induced nonconvulsive status epilepticus.

Authors:  F Anzellotti; L Ricciardi; D Monaco; F Ciccocioppo; I Borrelli; H Zhuzhuni; M Onofrj
Journal:  Neurol Sci       Date:  2011-07-01       Impact factor: 3.307

Review 3.  Clinically relevant drug interactions with antiepileptic drugs.

Authors:  Emilio Perucca
Journal:  Br J Clin Pharmacol       Date:  2006-03       Impact factor: 4.335

Review 4.  A Scoping Review of Medications Studied in Pediatric Polypharmacy Research.

Authors:  Alexis E Horace; Negar Golchin; Elia M Pestana Knight; Neal V Dawson; Xuan Ma; James A Feinstein; Hannah K Johnson; Lawrence Kleinman; Paul M Bakaki
Journal:  Paediatr Drugs       Date:  2020-02       Impact factor: 3.022

5.  Frequency of Toxoplasma and Toxocara Sp. Antibodies in Epileptic Patients, in South Western Iran.

Authors:  Sudabeh Allahdin; Shahram Khademvatan; Abdollah Rafiei; Aliakbar Momen; Reza Rafiei
Journal:  Iran J Child Neurol       Date:  2015

Review 6.  The gut microbiome and epilepsy.

Authors:  Maria Dahlin; Stefanie Prast-Nielsen
Journal:  EBioMedicine       Date:  2019-05-31       Impact factor: 8.143

7.  Seizure modulation by the gut microbiota and tryptophan-kynurenine metabolism in an animal model of infantile spasms.

Authors:  Chunlong Mu; Anamika Choudhary; Shyamchand Mayengbam; Karlene T Barrett; Jong M Rho; Jane Shearer; Morris H Scantlebury
Journal:  EBioMedicine       Date:  2022-01-25       Impact factor: 8.143

8.  Polysaccharides, Next Potential Agent for the Treatment of Epilepsy?

Authors:  Xuemin Xie; Youliang Wu; Haitao Xie; Haiyan Wang; Xiaojing Zhang; Jiabin Yu; Shaofang Zhu; Jing Zhao; Lisen Sui; Shaoping Li
Journal:  Front Pharmacol       Date:  2022-03-18       Impact factor: 5.810

9.  Thiazoles with cyclopropyl fragment as antifungal, anticonvulsant, and anti-Toxoplasma gondii agents: synthesis, toxicity evaluation, and molecular docking study.

Authors:  Krzysztof Z Łączkowski; Natalia Konklewska; Anna Biernasiuk; Anna Malm; Kinga Sałat; Anna Furgała; Katarzyna Dzitko; Adrian Bekier; Angelika Baranowska-Łączkowska; Agata Paneth
Journal:  Med Chem Res       Date:  2018-07-21       Impact factor: 1.965

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.